176 related articles for article (PubMed ID: 34905470)
1. Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11.
Chen Y; Tang W; Zhu X; Zhang L; Zhu Y; Xiao H; Xu J; Fang Y; Li X; Tang C; Shi J
Bioengineered; 2021 Dec; 12(2):11506-11519. PubMed ID: 34905470
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt/β-catenin signaling pathway.
Chen Y; Li X; Xu J; Xiao H; Tang C; Liang W; Zhu X; Fang Y; Wang H; Shi J
Bioengineered; 2022 Feb; 13(2):3526-3536. PubMed ID: 35200072
[TBL] [Abstract][Full Text] [Related]
3. Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65.
Lu T; Jackson MW; Wang B; Yang M; Chance MR; Miyagi M; Gudkov AV; Stark GR
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):46-51. PubMed ID: 20080798
[TBL] [Abstract][Full Text] [Related]
4. All-trans retinoic acid reverses epithelial-mesenchymal transition in paclitaxel-resistant cells by inhibiting nuclear factor kappa B and upregulating gap junctions.
Shi G; Zheng X; Wu X; Wang S; Wang Y; Xing F
Cancer Sci; 2019 Jan; 110(1):379-388. PubMed ID: 30375704
[TBL] [Abstract][Full Text] [Related]
5. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
Zang H; Li Y; Zhang X; Huang G
Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y
Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
9. RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression.
Wang M; Zhang Y; Xu Z; Qian P; Sun W; Wang X; Jian Z; Xia T; Xu Y; Tang J
Cell Commun Signal; 2020 Aug; 18(1):128. PubMed ID: 32807176
[TBL] [Abstract][Full Text] [Related]
10. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway.
Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319
[TBL] [Abstract][Full Text] [Related]
11. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
12. The MyD88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK-3β and MyD88/NF-κB signalling pathways.
Liu JH; Chen C; Li ZY; Zou ZM; Gao DC; Zhang X; Kuang XW; Sun ZH; Zheng WJ; Zhou P; Sun SR
Exp Cell Res; 2020 Sep; 394(2):112157. PubMed ID: 32610185
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells.
Wang YY; Yan L; Yang S; Xu HN; Chen TT; Dong ZY; Chen SL; Wang WR; Yang QL; Chen CJ
J Cell Physiol; 2019 Dec; 234(12):23202-23215. PubMed ID: 31215650
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2.
He J; Wang J; Li S; Li T; Chen K; Zhang S
Cancer Sci; 2020 Oct; 111(10):3550-3563. PubMed ID: 32726486
[TBL] [Abstract][Full Text] [Related]
15. LINC00160 mediated paclitaxel-And doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ.
Wu H; Gu J; Zhou D; Cheng W; Wang Y; Wang Q; Wang X
J Cell Mol Med; 2020 Aug; 24(15):8589-8602. PubMed ID: 32652877
[TBL] [Abstract][Full Text] [Related]
16. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
Zhao J; Zhang Q; Zou G; Gao G; Yue Q
J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
[TBL] [Abstract][Full Text] [Related]
17. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
18. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
19. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.
Chen YM; Liu Y; Wei HY; Lv KZ; Fu P
Tumour Biol; 2016 Aug; 37(8):10861-70. PubMed ID: 26883251
[TBL] [Abstract][Full Text] [Related]
20. Silence of TPPP3 suppresses cell proliferation, invasion and migration via inactivating NF-κB/COX2 signal pathway in breast cancer cell.
Ren Q; Hou Y; Li X; Fan X
Cell Biochem Funct; 2020 Aug; 38(6):773-781. PubMed ID: 32515139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
